UiPath (NYSE:PATH - Get Free Report)'s stock had its "buy" rating reiterated by research analysts at Needham & Company LLC in a report released on Friday,Benzinga reports. They presently have a $15.00 target price on the stock. Needham & Company LLC's target price suggests a potential upside of 29.30% from the company's current price.
A number of other analysts also recently issued reports on PATH. William Blair reaffirmed a "hold" rating on shares of UiPath in a research note on Thursday, March 12th. Weiss Ratings reissued a "hold (c)" rating on shares of UiPath in a research report on Friday, March 27th. Morgan Stanley raised UiPath from an "equal weight" rating to a "positive" rating in a research report on Friday, March 13th. Wall Street Zen downgraded UiPath from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 28th. Finally, UBS Group cut their price objective on UiPath from $17.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, March 12th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $14.07.
Read Our Latest Research Report on PATH
UiPath Stock Up 4.0%
Shares of PATH opened at $11.60 on Friday. UiPath has a 52-week low of $9.20 and a 52-week high of $19.84. The company has a market capitalization of $6.08 billion, a PE ratio of 22.31, a price-to-earnings-growth ratio of 1.83 and a beta of 0.91. The stock has a fifty day simple moving average of $10.74 and a two-hundred day simple moving average of $12.91.
UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Thursday, May 28th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.15. UiPath had a return on equity of 5.69% and a net margin of 17.53%.The business had revenue of $418.38 million during the quarter, compared to the consensus estimate of $397.54 million. During the same period last year, the company earned $0.11 EPS. The company's revenue for the quarter was up 17.3% on a year-over-year basis. As a group, equities analysts anticipate that UiPath will post 0.32 earnings per share for the current fiscal year.
Hedge Funds Weigh In On UiPath
Several institutional investors have recently bought and sold shares of the company. Glenmede Trust Co. NA grew its position in UiPath by 35.7% in the 1st quarter. Glenmede Trust Co. NA now owns 950,460 shares of the company's stock valued at $10,550,000 after acquiring an additional 249,969 shares in the last quarter. Bank of America Corp DE grew its position in shares of UiPath by 13.2% during the first quarter. Bank of America Corp DE now owns 10,046,699 shares of the company's stock worth $111,518,000 after buying an additional 1,170,285 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of UiPath by 9.9% during the first quarter. Janus Henderson Group PLC now owns 193,289 shares of the company's stock worth $2,148,000 after buying an additional 17,489 shares in the last quarter. IFS Group LLC acquired a new position in shares of UiPath during the first quarter worth about $448,000. Finally, Amundi grew its position in shares of UiPath by 8.5% during the first quarter. Amundi now owns 366,456 shares of the company's stock worth $4,068,000 after buying an additional 28,691 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.
More UiPath News
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: UiPath reported first-quarter fiscal 2027 revenue of about $418.4 million, above Wall Street expectations, and said annual recurring revenue rose 12% year over year to $1.901 billion, suggesting continued momentum in its automation and AI platform. UiPath Reports First Quarter Fiscal 2027 Financial Results
- Positive Sentiment: The company said agentic products are moving from pilot to production, and a new Deloitte partnership to integrate UiPath Test Cloud into Deloitte’s platform highlights growing enterprise adoption potential for its AI-driven automation tools. UiPath Deloitte Deal Highlights Agentic AI Testing And Adoption Potential
- Positive Sentiment: Traders bought unusually large volume of UiPath call options, which can signal bullish expectations heading into and following the earnings release. Traders Buy Large Volume of UiPath Call Options NYSE: PATH
- Neutral Sentiment: UiPath posted adjusted EPS of $0.15, matching estimates, but some headlines noted the stock slipped after hours because earnings were slightly below expectations even as guidance for Q2 and full year came in near or above forecasts. PATH Stock Slips After-Hours On Q1 Earnings Miss, But Q2 And Full-Year Guidance Beats Expectations
- Neutral Sentiment: Multiple transcript and earnings-snapshot articles echoed the same core message: solid revenue growth, in-line profit, and management commentary focused on accelerating growth and efficiency. UiPath (PATH) Q1 2027 Earnings Transcript
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.